Cargando…
Diagnostic and Therapeutic Strategy in Anaplastic (Malignant) Meningioma, CNS WHO Grade 3
SIMPLE SUMMARY: Only 1% of all meningioma diagnosis is classified as malignant (anaplastic) meningioma. Due to their rarity, clinical management of these tumors presents several gaps. In this review, we investigate current knowledge of anaplastic meningioma focusing on their pathological and radiolo...
Autores principales: | Di Nunno, Vincenzo, Giannini, Caterina, Asioli, Sofia, Conti, Alfredo, Furtner, Julia, Balestrini, Damiano, Tosoni, Alicia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562197/ https://www.ncbi.nlm.nih.gov/pubmed/36230612 http://dx.doi.org/10.3390/cancers14194689 |
Ejemplares similares
-
CAR-T cells neurotoxicity from consolidated practice in hematological malignancies to fledgling experience in CNS tumors: fill the gap
por: Gatto, Lidia, et al.
Publicado: (2023) -
Meningioma: not always a benign tumor. A review of advances in the treatment of meningiomas
por: Maggio, Ilaria, et al.
Publicado: (2021) -
Discovering the Molecular Landscape of Meningioma: The Struggle to Find New Therapeutic Targets
por: Maggio, Ilaria, et al.
Publicado: (2021) -
Extracerebral anaplastic meningioma
por: Carillio, Guido, et al.
Publicado: (2023) -
Loss of H3K27me3 in meningiomas: an independent marker for CNS WHO grade 2?
por: Behling, Felix, et al.
Publicado: (2023)